2 terminated. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
| Phase 2 | 1 | Terminated 1 |
Follow Obsessive-Compulsive Disorder: new trials by email Literature Review of Obsessive-Compulsive Disorder trials Research Report on Obsessive-Compulsive Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder Troriluzole (BHV-4157) - Obsessive Compulsive Disorder | Phase 3 | Terminated | Biohaven Pharmaceuticals, Inc. | 772 | 2021-03-30 | 2026-02-25 |
| Augmentation Study of Levetiracetam in Obsessive Compulsive Disorder Sertraline, Levetiracetam, Placebo - Obsessive-Compulsive Disorder | Phase 2 / Phase 3 | Terminated | Duke University | 12 | 2005-11-01 | 2013-04-11 |
Mental Disorders (2) · Anxiety Disorders (1)
Levetiracetam (1) · Sertraline (1)
Biohaven Pharmaceuticals, Inc. (1) · Duke University (1)
United States (2) · Canada (1) · Italy (1) · Netherlands (1) · Spain (1) · United Kingdom (1)